0548 GMT - Thomson Medical Group is unlikely to turn profitable in the short term, Maybank Research's Eric Ong says in a report. The Singapore-listed company posted a fiscal 1H net loss of S$12.9 million, with the magnitude of the loss catching the analyst off guard. The poor performance of its Malaysian operations and increased interest expenses related to the acquisition of FV Hospital in Vietnam were the main contributors. The healthcare-services provider probably needs more time to fully reap the benefits of maximizing its assets and enhancing margins in its key markets, Ong adds. The brokerage downgrades the stock to hold from buy and cuts the target price to S$0.05 from S$0.06. Shares are 2.2% lower at S$0.044. (ronnie.harui@wsj.com)
(END) Dow Jones Newswires
February 14, 2025 00:48 ET (05:48 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.